Written by Leigh Buchanan, Editor-at-Large for Inc. Magazine.
Written by Brian Neman, Co-Founder & CEO, Sanguine for Pharmaceutical Outsouring
Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom LifeLines Magazine
Written by Amy Neuer, Applied Clinical Trials
Antibody treatments could be a bridge to a vaccine Written by Karin Brulliard and Carolyn Y. Johnson...
Interview with Daniel Levine, The Bio Report One of the challenges to securing the participation of ...
Written by Catheine Ho, San Francisco Chronicle
Written by Brian Neman, Co-Founder & CEO, Sanguine for Biocom’s Biocommunique Newsletter